Liquidia Technologies Inc (LQDA)

NASDAQ
Currency in USD
14.210
-0.270(-1.86%)
Real-time Data·
LQDA Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
LQDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.11514.560
52 wk Range
8.26019.410
Key Statistics
Edit
Prev. Close
14.48
Open
14.56
Day's Range
14.115-14.56
52 wk Range
8.26-19.41
Volume
438.77K
Average Volume (3m)
2.13M
1-Year Change
14.83%
Book Value / Share
0.58
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LQDA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.300
Upside
+113.23%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Liquidia Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Employees
170

Liquidia Technologies Inc Earnings Call Summary for Q1/2025

  • Q1 2025 net loss widened to $38.4M from $30.1M in Q1 2024; revenue slightly up to $3.1M; EPS of -$0.45 missed -$0.40 forecast
  • Stock fell 1.1% pre-market; company maintains strong liquidity with 4.43 current ratio despite ongoing losses
  • Preparing for Eutrebia launch post-May 24 PDUFA date; R&D expenses down 31%, G&A up 48% year-over-year
  • Developing global study for L606 liposomal sustained-release treprostinil; expects gradual EPS improvement and revenue growth
  • Management confident in Eutrebia's market differentiation; analysts bullish despite competitive landscape and financial challenges
Last Updated: 08-05-2025, 07:08 pm
Read Full Transcript

Compare LQDA to Peers and Sector

Metrics to compare
LQDA
Peers
Sector
Relationship
P/E Ratio
−8.7x−3.4x−0.5x
PEG Ratio
0.460.000.00
Price/Book
24.3x2.3x2.6x
Price / LTM Sales
85.6x2.7x3.2x
Upside (Analyst Target)
124.4%171.2%46.0%
Fair Value Upside
Unlock27.6%6.3%Unlock

Analyst Ratings

9 Buy
0 Hold
1 Sell
Ratings:
10 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.300
(+113.23% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.45 / -0.40
Revenue / Forecast
3.12M / 3.83M
EPS Revisions
Last 90 days

LQDA Income Statement

FAQ

What Is the Liquidia Technologies (LQDA) Stock Price Today?

The Liquidia Technologies stock price today is 14.21.

What Stock Exchange Does Liquidia Technologies Trade On?

Liquidia Technologies is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Liquidia Technologies?

The stock symbol for Liquidia Technologies is "LQDA."

What Is the Liquidia Technologies Market Cap?

As of today, Liquidia Technologies market cap is 1.21B.

What Is Liquidia Technologies's Earnings Per Share (TTM)?

The Liquidia Technologies EPS (TTM) is -1.71.

When Is the Next Liquidia Technologies Earnings Date?

Liquidia Technologies will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is LQDA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Liquidia Technologies Stock Split?

Liquidia Technologies has split 0 times.

How Many Employees Does Liquidia Technologies Have?

Liquidia Technologies has 170 employees.

What is the current trading status of Liquidia Technologies (LQDA)?

As of 15 Jul 2025, Liquidia Technologies (LQDA) is trading at a price of 14.21, with a previous close of 14.48. The stock has fluctuated within a day range of 14.12 to 14.56, while its 52-week range spans from 8.26 to 19.41.

What Is Liquidia Technologies (LQDA) Price Target According to Analysts?

The average 12-month price target for Liquidia Technologies is USD30.3, with a high estimate of USD41 and a low estimate of USD6. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +113.23% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.